<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 10.5: Pharmaco-microbiomics: The Impact of Common Medications on Gut Ecology</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1a5d48;
            margin: 35px 0 15px 0;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #059669;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e5e5;
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Comparison Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f0fdf4;
            color: #059669;
            padding: 15px;
            border-bottom: 2px solid #10B981;
            font-weight: 600;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            vertical-align: top;
        }

        .data-table tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .check-understanding .box-label {
            font-weight: 600;
            color: #8B6914;
            margin: 0 0 24px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
            font-size: 14px;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f3f4f6;
            border-radius: 14px;
            padding: 30px;
            margin: 40px 0;
            border-left: 6px solid #059669;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #059669;
            margin-bottom: 15px;
            display: block;
        }

        /* References Box */
        .references-box {
            background: #f9fafb;
            border-radius: 12px;
            padding: 30px;
            margin-top: 50px;
            font-size: 14px;
            color: #4b5563;
            border: 1px solid #e5e7eb;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #374151;
            font-size: 16px;
        }

        .references-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .references-list li {
            margin-bottom: 10px;
            padding-left: 20px;
            position: relative;
        }

        .references-list li::before {
            content: "â€¢";
            position: absolute;
            left: 0;
            color: #10B981;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        @media (max-width: 768px) {
            .toc-list { grid-template-columns: 1fr; }
            .lesson-container { padding: 20px 15px; }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 10: Advanced Clinical Applications & Specialized Populations</p>
            <h1 class="lesson-title">Lesson 5: Pharmaco-microbiomics: The Impact of Common Medications on Gut Ecology</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Clinical Integration</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#intro"><span class="section-num">1</span>The Bidirectional Interaction</a></li>
                <li><a href="#ppi-nsaid"><span class="section-num">2</span>PPIs and NSAIDs</a></li>
                <li><a href="#metformin"><span class="section-num">3</span>Metformin & Metabolic Ecology</a></li>
                <li><a href="#hormones"><span class="section-num">4</span>Contraceptives & The Estrobolome</a></li>
                <li><a href="#efficacy"><span class="section-num">5</span>Microbial Drug Metabolism</a></li>
                <li><a href="#mitigation"><span class="section-num">6</span>Clinical Support Protocols</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Define the field of <span class="highlight">pharmaco-microbiomics</span> and its relevance to clinical gut health coaching.</li>
                <li>Analyze how Proton Pump Inhibitors (PPIs) and NSAIDs disrupt the intestinal barrier and microbial diversity.</li>
                <li>Evaluate the dual role of Metformin in modulating the microbiome and its associated GI side effects.</li>
                <li>Explain the interaction between oral contraceptives, HRT, and the estrobolome.</li>
                <li>Develop evidence-based strategies to mitigate medication-induced dysbiosis while maintaining therapeutic compliance.</li>
            </ul>
        </div>

        <h2 id="intro">1. The New Frontier: Pharmaco-microbiomics</h2>
        <p>While antibiotics have long been recognized for their "scorched earth" effect on the gut microbiome, a paradigm shift is occurring in clinical science. We now understand that a vast array of <span class="highlight">non-antibiotic medications</span>â€”from common painkillers to blood pressure medicationsâ€”exert profound selective pressure on our microbial inhabitants. This field, known as <strong>pharmaco-microbiomics</strong>, investigates the bidirectional relationship between drugs and the microbiome.</p>

        <p>A landmark 2018 study published in <i>Nature</i> screened over 1,000 non-antibiotic drugs and found that <span class="stat-highlight">24% (nearly 1 in 4) inhibited the growth of at least one human gut bacterial strain</span>. This means that many clients seeking gut health support may be experiencing "collateral damage" from necessary pharmaceutical interventions they don't even associate with their digestive symptoms.</p>

        <p>As an AccrediPro Certified Coach, your role is not to advise on medication changes (which is the physician's domain) but to understand these interactions so you can provide targeted microbial support that minimizes side effects and optimizes the client's overall health trajectory.</p>

        <h2 id="ppi-nsaid">2. Beyond Antibiotics: PPIs and NSAIDs</h2>
        <p>Proton Pump Inhibitors (PPIs) and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) are among the most frequently used medications globally. Their impact on gut ecology is often more insidious than that of antibiotics because they are frequently used long-term.</p>

        <h3>Proton Pump Inhibitors (PPIs)</h3>
        <p>PPIs function by inhibiting the H+/K+-ATPase pump in gastric parietal cells, significantly raising stomach pH. While effective for GERD, this disrupts the <span class="highlight">acid barrier</span>â€”the primary defense against oral and environmental pathogens. Research indicates that PPI users have a significantly higher abundance of oral-associated bacteria (e.g., <i>Streptococcus</i> and <i>Staphylococcus</i>) in their lower GI tract.</p>
        
        <p>A 2023 meta-analysis found that PPI use is associated with a <span class="stat-highlight">1.7 to 3.1-fold increased risk</span> of developing Small Intestinal Bacterial Overgrowth (SIBO). By altering the pH, PPIs favor the growth of <i>Firmicutes</i> and decrease the abundance of beneficial <i>Bacteroidetes</i>, creating a state of chronic dysbiosis that can mimic or exacerbate IBS symptoms.</p>

        <h3>NSAIDs (Ibuprofen, Naproxen, Aspirin)</h3>
        <p>NSAIDs cause gut damage through two primary mechanisms: direct topical irritation and systemic inhibition of prostaglandins (which maintain the mucosal lining). This often results in "NSAID-enteropathy," characterized by increased <span class="highlight">intestinal permeability</span> (leaky gut) and mucosal ulceration. From a microbial perspective, NSAIDs have been shown to deplete <i>Lactobacillus</i> species while promoting the growth of pro-inflammatory Proteobacteria.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ“‹</div>
                <div>
                    <p class="box-label">Case Study: The "Silent" Dysbiosis</p>
                    <p style="color: rgba(255,255,255,0.8); margin: 0; font-size: 13px;">Chronic PPI Use & SIBO</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Client:</strong> Sarah, 48, presenting with chronic bloating, vitamin B12 deficiency, and intermittent diarrhea.</p>
                <p><strong>History:</strong> Sarah had been on Omeprazole (PPI) for 7 years for "acid reflux." She recently started a high-dose Ibuprofen regimen for joint pain. Despite a "clean" diet, her bloating was worsening.</p>
                <p><strong>Intervention:</strong> Using <i>The Method</i>, we focused on "Replacing" digestive support (using ACV and bitter herbs to stimulate natural secretions, with physician approval to taper PPIs) and "Reinoculating" with specific <i>Bifidobacterium</i> strains.</p>
                <p><strong>Outcome:</strong> After 12 weeks, Sarah's hydrogen breath test for SIBO normalized, and her bloating reduced by 80%. Her B12 levels stabilized as her intrinsic factor function and microbial absorption improved.</p>
            </div>
        </div>

        <h2 id="metformin">3. Metformin: A Double-Edged Sword</h2>
        <p>Metformin, the first-line therapy for Type 2 Diabetes, presents a fascinating case of pharmaco-microbiomics. Up to <span class="stat-highlight">30% of patients</span> experience significant GI side effects, including diarrhea and nausea, which often lead to medication non-compliance.</p>

        <p>However, many of Metformin's therapeutic benefits are actually mediated <i>through</i> the microbiome. Metformin has been shown to:</p>
        <ul>
            <li>Increase the abundance of <span class="highlight">Akkermansia muciniphila</span>, a keystone species that strengthens the gut barrier and improves insulin sensitivity.</li>
            <li>Promote the growth of Short-Chain Fatty Acid (SCFA) producing bacteria, particularly those producing butyrate.</li>
            <li>Increase the secretion of GLP-1 (glucagon-like peptide-1) via microbial pathways.</li>
        </ul>

        <p>The "side effects" are often a result of rapid shifts in microbial populations and the accumulation of bile acids in the colon. Managing the microbiome can allow clients to tolerate this essential medication more effectively.</p>

        <h2 id="hormones">4. Oral Contraceptives and the Estrobolome</h2>
        <p>Building on our deep dive into the <strong>Estrobolome</strong> (Module 9, Lesson 1), we must address how exogenous hormones (BCPs and HRT) impact gut health. Oral contraceptives can alter the biliary composition, increasing the risk of gallstones and sluggish bile flow.</p>

        <p>Furthermore, synthetic hormones can induce a state of dysbiosis that alters the activity of <span class="highlight">beta-glucuronidase</span>. This enzyme, produced by specific gut bacteria, is responsible for deconjugating estrogens, allowing them to be reabsorbed into the bloodstream. When this process is disrupted by medication-induced dysbiosis, it can lead to "estrogen dominance" symptoms despite the use of hormonal regulators.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Drug Class</th>
                        <th>Common Examples</th>
                        <th>Microbial Impact</th>
                        <th>Clinical Symptom</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>PPIs</strong></td>
                        <td>Omeprazole, Esomeprazole</td>
                        <td>Loss of acid barrier; Oral bacteria translocation</td>
                        <td>SIBO, B12 deficiency, C. diff risk</td>
                    </tr>
                    <tr>
                        <td><strong>NSAIDs</strong></td>
                        <td>Ibuprofen, Naproxen</td>
                        <td>Depletion of <i>Lactobacillus</i>; Increased LPS</td>
                        <td>Leaky gut, Gastritis, Iron deficiency</td>
                    </tr>
                    <tr>
                        <td><strong>Metformin</strong></td>
                        <td>Glucophage</td>
                        <td>Increase in <i>Akkermansia</i> & <i>Escherichia</i></td>
                        <td>Diarrhea, Bloating, Improved Insulin Sensitivity</td>
                    </tr>
                    <tr>
                        <td><strong>Statins</strong></td>
                        <td>Atorvastatin, Simvastatin</td>
                        <td>Alteration of bile acid metabolism</td>
                        <td>Myalgia (possibly microbiome-linked)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="efficacy">5. How Microbes Determine Drug Efficacy & Toxicity</h2>
        <p>The microbiome doesn't just react to drugs; it actively metabolizes them. This can happen in several ways:</p>
        
        <p><span class="highlight">1. Activation:</span> Some drugs are "prodrugs" that require microbial enzymes to become active. For example, Sulfasalazine (used for IBD) is cleaved by bacterial azoreductases into its active anti-inflammatory component.</p>
        
        <p><span class="highlight">2. Inactivation:</span> Microbes can degrade drugs before they reach systemic circulation. A classic example is <i>Eggerthella lenta</i>, which can inactivate the cardiac drug Digoxin. If a patient has high levels of <i>E. lenta</i>, they may require a higher dose of the drug to see an effect.</p>
        
        <p><span class="highlight">3. Toxification:</span> Microbes can turn a safe drug into a toxic metabolite. The chemotherapy drug Irinotecan is deactivated by the liver, but gut bacteria producing beta-glucuronidase can "reactivate" it in the colon, causing severe, life-threatening diarrhea.</p>

        <h2 id="mitigation">6. Clinical Mitigation Strategies</h2>
        <p>As a coach, your strategy should focus on the "Protect and Restore" phase of <i>The Method</i>. When a client must remain on these medications, the following evidence-based protocols can be implemented:</p>

        <div class="principle-card">
            <div class="principle-title">The PPI Support Protocol</div>
            <div class="principle-text">
                Focus on acidic digestive aids (if tolerated) like Betaine HCl or Apple Cider Vinegar to mimic the lost acid barrier during meals. Supplement with <i>Saccharomyces boulardii</i> to prevent opportunistic infections like <i>C. difficile</i>.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">The NSAID Recovery Protocol</div>
            <div class="principle-text">
                Prioritize mucosal support nutrients: Zinc Carnosine, L-Glutamine, and deglycyrrhizinated licorice (DGL). Use <i>Lactobacillus rhamnosus GG</i>, which has been shown in clinical trials to reduce NSAID-induced intestinal permeability.
            </div>
        </div>

        <div class="principle-card">
            <div class="principle-title">The Metformin Tolerance Protocol</div>
            <div class="principle-text">
                Introduce fermentable fibers (partially hydrolyzed guar gum) slowly to support the shift in SCFAs. Consider a high-quality multi-strain probiotic containing <i>Bifidobacterium animalis</i> to help regulate bowel transit time.
            </div>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <p class="question-text">1. Why does long-term PPI use increase the risk of SIBO?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    PPIs raise stomach pH, neutralizing the "acid barrier." This allows bacteria from the oral cavity and upper respiratory tract to survive transit through the stomach and colonize the small intestine, where they would normally be inhibited by low pH.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. How does the microbiome contribute to "estrogen dominance" in women taking oral contraceptives?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Medication-induced dysbiosis can increase the production of the enzyme beta-glucuronidase. This enzyme deconjugates estrogen in the gut, preventing its excretion and allowing it to be reabsorbed into systemic circulation, effectively increasing the total estrogen load.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <span class="box-label">Key Takeaways</span>
            <ul>
                <li>Pharmaco-microbiomics is a bidirectional interaction: drugs change the gut, and the gut changes the drug's effect.</li>
                <li>Nearly 25% of common non-antibiotic medications have significant antimicrobial effects on beneficial gut flora.</li>
                <li>PPIs disrupt the acid barrier, leading to oral-gut translocation and a 2-3x increased risk of SIBO.</li>
                <li>Metformin's benefits are partly microbial (increasing <i>Akkermansia</i>), but its side effects are also driven by microbial shifts.</li>
                <li>Practitioners must use targeted "Protect and Restore" protocols (e.g., Zinc Carnosine for NSAIDs, S. boulardii for PPIs) to support clients on necessary medications.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul class="references-list">
                <li>Maier, L. et al. (2018). "Extensive impact of non-antibiotic drugs on human gut bacteria." <i>Nature</i>.</li>
                <li>Jackson, M.A. et al. (2016). "Proton pump inhibitors alter the human gut microbiome." <i>Gut</i>.</li>
                <li>Wu, H. et al. (2017). "Metformin alters the gut microbiome of individuals with newly diagnosed type 2 diabetes, contributing to the therapeutic effects of the drug." <i>Nature Medicine</i>.</li>
                <li>Zimmermann, M. et al. (2019). "Mapping human microbiome drug metabolism by gut bacteria and their genes." <i>Nature</i>.</li>
                <li>Bjarnason, I. et al. (2018). "NSAID-induced secondary gastric and small intestinal damage." <i>Gastroenterology</i>.</li>
                <li>Kastl, A.J. et al. (2022). "The Impact of Common Medications on the Gut Microbiome." <i>Current Gastroenterology Reports</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-Horizontal-1.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Gut Health & Microbiome Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. For professional use only.</p>
        </footer>
    </div>
</body>

</html>